Skip to main content

Millicom downgraded to "hold"

NEW YORK, September 7 (newratings.com) - Analysts at Stifel Nicolaus & Company downgrade Millicom (ticker: MICC) from "buy" to "hold." [more]

Cymer downgraded to "equal weight"

NEW YORK, September 7 (newratings.com) - Analysts at Barclays Capital downgrade Cymer (ticker: CYMI) from "overweight" to "equal weight." The target price has been reduced from $42 to $30. [more]

LTX-Credence downgraded to "equal weight"

NEW YORK, September 7 (newratings.com) - Analysts at Barclays Capital downgrade LTX-Credence (ticker: LTXC) from "overweight" to "equal weight." The target price is set to $4. [more]

Pacer International upgraded to "buy"

NEW YORK, September 7 (newratings.com) - Analysts at Stifel Nicolaus & Company upgrade Pacer International (ticker: PACR) from "hold" to "buy." The target price is set to $8. [more]

Heartland Express upgraded to "buy"

NEW YORK, September 7 (newratings.com) - Analysts at Stifel Nicolaus & Company upgrade Heartland Express (ticker: HTLD) from "hold" to "buy." The target price is set to $19. [more]

Green Dot initiated with "neutral"

NEW YORK, September 7 (newratings.com) - Analysts at UBS initiate coverage of Green Dot (ticker: GDOT) with a "neutral" rating. The target price is set to $50. [more]

Healthcare Realty initiated with "neutral"

NEW YORK, September 7 (newratings.com) - Analysts at Hilliard Lyons initiate coverage of Healthcare Realty (ticker: HR) with a "neutral" rating. [more]

Envestnet initiated with "equal weight"

NEW YORK, September 7 (newratings.com) - Analysts at Barclays Capital initiate coverage of Envestnet Inc (ticker: ENV) with an "equal weight" rating. The target price is set to $11. [more]

McAfee downgraded to "equal weight"

NEW YORK, September 7 (newratings.com) - Analysts at Barclays Capital downgrade McAfee (ticker: MFE) from "overweight" to "equal weight." The target price has been raised from $36 to $48. [more]

Verigy downgraded to "underweight"

NEW YORK, September 7 (newratings.com) - Analysts at Barclays Capital downgrade Verigy Ltd (ticker: VRGY) from "equal weight" to "underweight." The target price has been reduced from $12 to $6. [more]

Syndicate content